Selegiline and Parkinson's disease. Protective and symptomatic considerations
Drugs
.
1990 May;39(5):646-51.
doi: 10.2165/00003495-199039050-00002.
Authors
L I Golbe
1
,
J W Langston
,
I Shoulson
Affiliation
1
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick.
PMID:
2112994
DOI:
10.2165/00003495-199039050-00002
No abstract available
Publication types
Review
MeSH terms
Humans
Parkinson Disease / drug therapy*
Phenethylamines / therapeutic use*
Selegiline / therapeutic use*
Substances
Phenethylamines
Selegiline